Maximova Olga A, Faucette Lawrence J, Ward Jerrold M, Murphy Brian R, Pletnev Alexander G
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892-3203, USA.
J Histochem Cytochem. 2009 Oct;57(10):973-89. doi: 10.1369/jhc.2009.954180. Epub 2009 Jul 6.
Flaviviruses such as tick-borne encephalitis virus, Japanese encephalitis virus, West Nile virus, and St. Louis encephalitis virus are important neurotropic human pathogens, typically causing a devastating and often fatal neuroinfection. Flaviviruses induce neuroinflammation with typical features of viral encephalitides, including inflammatory cell infiltration, activation of microglia, and neuronal degeneration. Development of safe and effective live-virus vaccines against neurotropic flavivirus infections demands a detailed knowledge of their neuropathogenesis in a primate host that is evolutionarily close to humans. Here, we used computerized morphometric analysis to quantitatively assess the cellular inflammatory responses in the central nervous system (CNS) of rhesus monkeys infected with three antigenically divergent attenuated flaviviruses. The kinetics, spatial pattern, and magnitude of microglial activation, trafficking of T and B cells, and changes in T cell subsets within the CNS define unique phenotypic signatures for each of the three viruses. Our results provide a benchmark for investigation of cellular inflammatory responses induced by attenuated flaviviruses in the CNS of primate hosts and provide insight into the neuropathogenesis of flavivirus encephalitis that might guide the development of safe and effective live-virus vaccines.
蜱传脑炎病毒、日本脑炎病毒、西尼罗河病毒和圣路易斯脑炎病毒等黄病毒是重要的嗜神经性人类病原体,通常会引发毁灭性且往往致命的神经感染。黄病毒会诱发具有病毒性脑炎典型特征的神经炎症,包括炎性细胞浸润、小胶质细胞活化和神经元变性。研发针对嗜神经性黄病毒感染的安全有效的活病毒疫苗,需要详细了解它们在与人类进化关系密切的灵长类宿主中的神经发病机制。在此,我们使用计算机形态计量分析来定量评估感染三种抗原性不同的减毒黄病毒的恒河猴中枢神经系统(CNS)中的细胞炎症反应。小胶质细胞活化的动力学、空间模式和程度、T细胞和B细胞的迁移以及中枢神经系统内T细胞亚群的变化为这三种病毒中的每一种定义了独特的表型特征。我们的结果为研究减毒黄病毒在灵长类宿主中枢神经系统中诱导的细胞炎症反应提供了一个基准,并为黄病毒脑炎的神经发病机制提供了见解,这可能会指导安全有效的活病毒疫苗的研发。